Rambam Health Care Campus (Rambam) has signed two new memoranda of understanding, forging alliances with AIG Hospitals and Bharat Biodesign to drive joint medical innovation and healthtech collaboration.
Last week, Dr. Yona Vaisbuch, a senior physician at Rambam's Department of Otolaryngology-Head & Neck Surgery and founding director of Biodesign Israel, returned from India after participating in the International Biodesign Conference. While there, he held a series of meetings that led to new understandings and the signing of two separate agreements with partners in India.
The first memoranda of understanding (MoU), signed with AIG Hospitals, based in Hyderabad, Telangana, focuses on accelerating medical innovation—from identifying clinical needs to piloting solutions in hospitals—through collaborations in clinical innovation, digital medical technologies, portable medical equipment for field use, and multidisciplinary training for clinical and engineering teams.
The second MoU, signed with Bharat Biodesign and the AI & Medtech Alliance Foundation (Telangana), establishes strategic collaboration in education, healthtech innovation, and regulatory development. This partnership expands the reach of the Stanford Biodesign methodology to both Israel and India, supporting the creation of ventures that can improve care worldwide.
As part of Vaisbuch’s participation in the APAC Biodesign Alliance Conference, the APAC Biodesign Alliance delegation was officially welcomed by Mr. N. Chandrababu Naidu, Chief Minister of Andhra Pradesh. During this meeting, Biodesign centers from around the world—including Biodesign Israel—presented their contributions to advancing healthcare innovation.
The Biodesign methodology was designed by Stanford University and serves as the professional foundation for these collaborations. This structured approach guides teams through identifying clinical needs, generating solutions, developing prototypes, feasibility testing, and preparing for regulatory approval and market entry. Rambam leads the Israeli Biodesign program, which connects clinicians, engineers, and entrepreneurs to advance joint initiatives. The program provides mentoring, access to testing infrastructure, and links to investment funds and industry partners.
“The collaboration enables rapid clinical validation and two-way knowledge exchange for the benefit of patients both in Israel and in partner countries,” says Vaisbuch.
Rambam emphasizes that this initiative is designed to serve patients in Israel and healthcare communities across the Indian subcontinent, by creating channels for research, education, and implementation. In the coming months, dedicated teams will define pilot sites, explore regulatory pathways to advance solutions that improve care quality, shorten wait times, and expand access to advanced medical services.
